Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Padsevonil

Various toxicity: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Rademacher M, et al. Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials. Epilepsia Open 7: 758-770, No. 4, 29 Sep 2022. Available from: URL: http://doi.org/10.1002/epi4.12656 Rademacher M, et al. Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials. Epilepsia Open 7: 758-770, No. 4, 29 Sep 2022. Available from: URL: http://​doi.​org/​10.​1002/​epi4.​12656
Metadaten
Titel
Padsevonil
Various toxicity: 5 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42003-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Succimer